Endeavor’s financial performance hampered by legal, integration costs

Evanston, Ill.-based Endeavor Health, formerly known as NorthShore-Edward-Elmhurst Health, reported a $51.3 million operating loss (-0.9% margin) in 2023, down from a $26.7 million loss (-0.5% margin) in 2022, as legal and integration costs hindered its financial performance. 

Advertisement

Endeavor, Illinois’ third-largest health system, spent $11.4 million on integration costs in 2023, compared to $40.9 million in 2022, according to financial documents published April 24. It also agreed to pay a $55 million settlement to resolve antitrust allegations raised after NorthShore’s acquisition of Highland Park (Ill.) Hospital in 2000.

Excluding the integration and legal expenses, Endeavor reported a $17.7 million operating gain in 2023.

Revenue for the nine-hospital system increased 4.8% year over year to $5.6 billion while expenses rose 4.8% to $5.58 billion. Labor costs increased 4.9% to $3.1 billion and supply costs grew by 2.4% to $1.9 billion. 

After factoring in nonoperating items, such as investment returns, Endeavor reported a net income of $470.2 million in 2023, compared to a net loss of $734.4 million in 2022. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.